A single-center retrospective study on the clinical features of thyrotoxic periodic paralysis.
Kota YamadaAkiyo TanabeMakiko HashimotoMitsuru OhsugiKohjiro UekiHiroshi KajioPublished in: PloS one (2024)
Considering that most patients with TPP have undiagnosed Graves' disease, distinguishing TPP from SPP based on clinical information and course alone is difficult in emergency settings. Therefore, for early detection and launch of specific treatment of Graves' disease, screening for thyroid hormone and anti-thyroid stimulating hormone receptor antibody levels is necessary when treating patients with periodic paralysis.